Page last updated: 2024-08-22

zirconium and ER-Negative PR-Negative HER2-Negative Breast Cancer

zirconium has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (40.00)	24.3611
2020's	3 (60.00)	2.80

Authors

Authors	Studies
Belitzky, E; Bothwell, ALM; Cavaliere, A; Gallezot, JD; Keler, T; Lee, S; Li, F; Liu, M; Maher, SE; Marquez-Nostra, B; Michelhaugh, SK; Mittal, S; Mulnix, T; Phadke, M	1
Boerner, JL; Kim, S; McKnight, BN; Viola, NT	1
Chen, D; Chen, Y; Cheng, K; Jiang, S; Lin, Z; Lu, M; Ming, L; Yang, R; Zhou, J	1
Abdel-Atti, D; Dilling, TR; Edwards, KJ; Evans, MJ; Henry, KE; Lewis, JS	1
Bensch, F; Boellaard, R; Bohorquez, SS; Brouwers, AH; de Crespigny, A; de Vries, EGE; Elias, SG; Fine, BM; Gietema, JA; Groen, HJM; Hiltermann, TJN; Jorritsma-Smit, A; Kok, IC; Kwee, TC; Lub-de Hooge, MN; Mancao, C; Oosting, SF; Schröder, CP; van der Veen, EL; van der Wekken, AJ; Williams, SP	1

Trials

1 trial(s) available for zirconium and ER-Negative PR-Negative HER2-Negative Breast Cancer

Article	Year
Nature medicine, 2018, Volume: 24, Issue:12 Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; B7-H1 Antigen; Biopsy; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Female; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Tissue Distribution; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms; Zirconium	2018

Article

Year

Nature medicine, 2018, Volume: 24, Issue:12

Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; B7-H1 Antigen; Biopsy; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Female; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Tissue Distribution; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms; Zirconium

2018

Other Studies

4 other study(ies) available for zirconium and ER-Negative PR-Negative HER2-Negative Breast Cancer

Article	Year
[89Zr]ZrDFO-CR011 PET Correlates with Response to Glycoprotein Nonmetastatic Melanoma B-targeted Therapy in Triple-negative Breast Cancer. Molecular cancer therapeutics, 2022, 03-01, Volume: 21, Issue:3 Topics: Glycoproteins; Humans; Melanoma; Membrane Glycoproteins; Positron-Emission Tomography; Radioisotopes; Triple Negative Breast Neoplasms; Zirconium	2022
Cetuximab PET delineated changes in cellular distribution of EGFR upon dasatinib treatment in triple negative breast cancer. Breast cancer research : BCR, 2020, 04-15, Volume: 22, Issue:1 Topics: Animals; Antineoplastic Agents, Immunological; Cell Line, Tumor; Cell Proliferation; Cetuximab; Dasatinib; Drug Resistance, Neoplasm; ErbB Receptors; Female; Humans; Mice; Mice, Nude; Positron-Emission Tomography; Protein Kinase Inhibitors; Radioisotopes; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays; Zirconium	2020
International journal of nanomedicine, 2020, Volume: 15 Topics: Adult; Aged; Animals; Antineoplastic Agents; Cell Line, Tumor; Chitosan; Female; Humans; Hyaluronan Receptors; Liposomes; Mice, Nude; Middle Aged; Molecular Docking Simulation; Molecular Targeted Therapy; Neoplastic Stem Cells; Positron-Emission Tomography; Radioisotopes; Tissue Distribution; Triple Negative Breast Neoplasms; Xanthones; Xenograft Model Antitumor Assays; Zirconium	2020
Noninvasive Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2018, Volume: 59, Issue:1 Topics: Animals; Biological Transport; Cell Line, Tumor; Cell Transformation, Neoplastic; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Mice; Positron-Emission Tomography; Proto-Oncogene Proteins c-myc; Radioisotopes; Transferrin; Triple Negative Breast Neoplasms; Zirconium	2018